1.Clinicopathological Study of 18 Cases of Inflammatory Myofibroblastic Tumors with Reference to ALK-1 Expression: 5-Year Experience in a Tertiary Care Center.
Ramesh Babu TELUGU ; Anne Jennifer PRABHU ; Nobin Babu KALAPPURAYIL ; John MATHAI ; Birla Roy GNANAMUTHU ; Marie Therese MANIPADAM
Journal of Pathology and Translational Medicine 2017;51(3):255-263
BACKGROUND: Inflammatory myofibroblastic tumor is a histopathologically distinctive neoplasm of children and young adults. According to World Health Organization (WHO) classification, inflammatory myofibroblastic tumor is an intermediate-grade tumor, with potential for recurrence and rare metastasis. There are no definite histopathologic, molecular, or cytogenetic features to predict malignant transformation, recurrence, or metastasis. METHODS: A 5-year retrospective study of histopathologically diagnosed inflammatory myofibroblastic tumors of various anatomic sites was conducted to correlate anaplastic lymphoma kinase-1 (ALK-1) expression with histological atypia, multicentric origin of tumor, recurrence, and metastasis. Clinical details of all the cases were noted from the clinical work station. Immunohistochemical stains for ALK-1 and other antibodies were performed. Statistical analysis was done using Fisher exact test. RESULTS: A total of 18 cases of inflammatory myofibroblastic tumors were found during the study period, of which 14 were classical. The female-male ratio was 1:1 and the mean age was 23.8 years. Histologically atypical (four cases) and multifocal tumors (three cases, multicentric in origin) were noted. Recurrence was noted in 30% of ALK-1 positive and 37.5% of ALK-1 negative cases, whereas metastasis to the lung, liver, and pelvic bone was noted in the ALK-1 positive group only. CONCLUSIONS: Overall, ALK-1 protein was expressed in 55.6% of inflammatory myofibroblastic tumors. There was no statistically significant correlation between ALK-1 expression, tumor type, recurrence and metastasis. However, ALK-1 immunohistochemistry is a useful diagnostic aid in the appropriate clinical and histomorphologic context.
Antibodies
;
Child
;
Classification
;
Coloring Agents
;
Cytogenetics
;
Humans
;
Immunohistochemistry
;
Liver
;
Lung
;
Lymphoma
;
Myofibroblasts*
;
Neoplasm Metastasis
;
Pelvic Bones
;
Recurrence
;
Retrospective Studies
;
Tertiary Care Centers*
;
Tertiary Healthcare*
;
World Health Organization
;
Young Adult
2.Embolization of the Device to the Left Pulmonary Artery after the Interventional Closure of Ruptured Sinus of Valsalva Aneurysm.
Lalit Kumar CHOUDHRY ; Vinay M RAO ; Birla Roy GNANAMUTHU ; Vishal AGRAWAL ; Ravi SHANKAR ; Ram PRASATH
The Korean Journal of Thoracic and Cardiovascular Surgery 2015;48(3):202-205
Formation of an aneurysm in the sinus of Valsalva of the aortic root is usually due to an area of congenital weakness in its wall. This aneurysm may progressively dilate and rupture into any of the cardiac chambers or into the pericardial cavity. Though this is conventionally treated by surgery, interventional therapy using various closure devices is becoming more common. Embolization of these closure devices may occur. We report a case of embolization of such a device into the left pulmonary artery which during surgical retrieval, unmasked the hidden ventricular septal defect (VSD). Therefore one has to be cautious while making a diagnosis of rupture of the sinus of Valsalva of right coronary sinus without VSD.
Aneurysm*
;
Coronary Sinus
;
Diagnosis
;
Heart Septal Defects, Ventricular
;
Pulmonary Artery*
;
Rupture
;
Sinus of Valsalva*